-
Mashup Score: 7
We are looking for new combination treatments to outsmart cancer and prevent drug resistance. Help us find better cancer treatment options by donating today.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers - 2 year(s) ago
An immunotherapy combination could be better than standard ‘Extreme’ chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
"Our findings point towards a positive trend in survival when using a new #ImmunotherapyCombination for patients with #HeadAndNeckCancer and could be a better option than the standard 'Extreme' treatment.'' – Professor Kevin Harrington⬇️ https://t.co/4Hf88cDSfN #UnlockTreatments https://t.co/XkJhwP6Rlo
-
-
Mashup Score: 7
We are looking for new combination treatments to outsmart cancer and prevent drug resistance. Help us find better cancer treatment options by donating today.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Combination drug therapy can significantly benefit patients with newly diagnosed blood cancer - 2 year(s) ago
A four-drug combination therapy that includes the novel drug carfilzomib can slow the progression of the blood cancer myeloma in patients who have been newly diagnosed with the disease, a phase III study has shown.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2ICR Discovery Club showcases how we combine therapies to target hard-to-treat cancers - 2 year(s) ago
Discovery Club members gathered at the Science Museum in London to learn how our researchers are transforming cancer care for patients with innovative combination therapies.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
We are looking for new combination treatments to outsmart cancer and prevent drug resistance. Help us find better cancer treatment options by donating today.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
We are looking for new combination treatments to outsmart cancer and prevent drug resistance. Help us find better cancer treatment options by donating today.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6
A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8
We are looking for new combination treatments to outsmart cancer and prevent drug resistance. Help us find better cancer treatment options by donating today.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
We are looking for new combination treatments to outsmart cancer and prevent drug resistance. Help us find better cancer treatment options by donating today.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Many #Cancer patients are treated with a combination of two or more drugs or different types of therapy. We're working to discover clever new #CombinationTherapies to continue outsmarting cancer. Please donate today to help us #UnlockTreatments: https://t.co/As7ftmLYiz https://t.co/06MJ6pIY66